Adverse events252

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 252

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anterior chamber pigmentation	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Study Eye	1	37	1
other	Anterior chamber pigmentation	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Non-study Eye	0	37	0
other	Anterior chamber pigmentation	Eye disorders	Omaveloxolone Ophthalmic Suspension 0.5%: Study Eye	0	33	0
other	Anterior chamber pigmentation	Eye disorders	Omaveloxolone Ophthalmic Suspension 0.5%: Non-study Eye	0	33	0
other	Anterior chamber pigmentation	Eye disorders	Placebo: Study Eye	0	39	0
other	Anterior chamber pigmentation	Eye disorders	Placebo: Non-study Eye	0	39	0
other	Anterior chamber pigmentation	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Non-ocular AE	0	37	0
other	Anterior chamber pigmentation	Eye disorders	Omaveloxolone Ophthalmic Suspension 0.5%: Non-ocular AE	0	33	0
other	Anterior chamber pigmentation	Eye disorders	Placebo: Non-ocular AE	0	39	0
other	Blepharitis	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Study Eye	0	37	0
other	Blepharitis	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Non-study Eye	0	37	0
other	Blepharitis	Eye disorders	Omaveloxolone Ophthalmic Suspension 0.5%: Study Eye	0	33	0
other	Blepharitis	Eye disorders	Omaveloxolone Ophthalmic Suspension 0.5%: Non-study Eye	0	33	0
other	Blepharitis	Eye disorders	Placebo: Study Eye	0	39	0
other	Blepharitis	Eye disorders	Placebo: Non-study Eye	1	39	1
other	Blepharitis	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Non-ocular AE	0	37	0
other	Blepharitis	Eye disorders	Omaveloxolone Ophthalmic Suspension 0.5%: Non-ocular AE	0	33	0
other	Blepharitis	Eye disorders	Placebo: Non-ocular AE	0	39	0
other	Ciliary hyperaemia	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Study Eye	1	37	1
other	Ciliary hyperaemia	Eye disorders	Omaveloxolone Ophthalmic Suspension 1.0%: Non-study Eye	0	37	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02065375/events

API reference For AI assistants

Adverse events252

Sources 3

Read this list from software.